Summary & Overview
HCPCS J7636: Atropine Inhalation Solution, Compounded, Unit Dose
HCPCS Level II code J7636 identifies a compounded inhalation formulation of atropine supplied in unit-dose form and billed per milligram for administration via durable medical equipment. This designation matters nationally because it captures billing for a niche but clinically important modality—nebulized anticholinergic therapy provided outside of standard pharmacy-dispensed prepackaged drugs—affecting payer coverage, DME billing workflows, and compound-drug oversight. Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for the use of inhaled atropine, typical sites of service where the drug supply is billed (home use with nebulizers, long-term care, outpatient infusion clinics), and operational considerations for billing this unit-dose, per-milligram drug line item. The publication also outlines benchmarks and common coverage themes for major payers, highlights relevant policy and billing nuances for compounded inhalation products supplied through DME, and summarizes documentation elements typically expected for claims. Data not available in the input where specific payer policies, taxonomies, ICD-10 mappings, and related codes are required.
Billing Code Overview
HCPCS Level II code J7636 describes Atropine, inhalation solution, compounded product, administered through DME, unit dose form, per milligram. This code represents a compounded inhalation medication formulation of atropine provided in unit-dose packaging and intended for administration via durable medical equipment (DME), reflecting a drug supply line item billed per milligram.
-
Service type: Compounded inhalation drug administration (drug supply line item)
-
Typical site of service: Home or outpatient settings when a patient uses DME (such as a nebulizer) for inhaled therapy; can also apply in long-term care or ambulatory infusion clinics that bill separately for compounded inhalation medications.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient with chronic obstructive pulmonary disease (COPD) or bronchospasm refractory to standard bronchodilators presents for inhaled anticholinergic therapy. The compounded inhalation solution J7636 (atropine, inhalation solution, compounded product, unit dose form, per milligram) is prepared by pharmacy and administered via durable medical equipment (nebulizer) in an outpatient infusion clinic, pulmonary clinic procedure room, or skilled nursing facility. The typical workflow: physician documents medical necessity and selects J7636 per dose and milligram unit; pharmacy compounds unit-dose vials labelled with concentration and milligram amount; nursing personnel or respiratory therapist verifies dose, prepares the nebulizer, administers the inhalation treatment, monitors vital signs and respiratory status during and after administration, documents dose, lot number, route (inhalation via DME), and any adverse reactions; billing uses the HCPCS code J7636 with appropriate modifier(s) to reflect unusual circumstances or payer-specific requirements. Common clinical indications include acute bronchospasm not responding to first-line inhaled beta-agonists or short-acting muscarinic antagonist therapy, severe bronchoconstriction in COPD exacerbation when nebulized anticholinergic is clinically indicated, or when commercially available formulations are unsuitable and a compounded unit-dose is required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|